A repurposed, blood gene signature is associated with poor outcomes in SARS-CoV-2
Juan-Guardela, B. M.; Sun, J.; Zhang, T.; Xu, B.; Michaud, G.; Herazo-Maya, J. D.
Show abstract
Poor outcomes after SARS-CoV-2 infection are difficult to predict. Survivors may develop pulmonary fibrosis. We previously identified a 52-gene signature in peripheral blood, predictive of mortality in Idiopathic Pulmonary Fibrosis. In this study, we analyzed this signature in SARS-CoV-2 infected individuals and identified genomic risk profiles with significant differences in outcomes. Analysis of single cell expression data shows that monocytes, red blood cells, neutrophils and dendritic cells are the cellular source of the high risk gene signature.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Single-Cell Mass Cytometry on Peripheral Blood Identifies Immune Cell Subsets Associated with Primary Biliary Cholangitis 93%
- Interpretable machine learning identifies paediatric Systemic Lupus Erythematosus subtypes based on gene expression data 93%
- Meta-analysis reveals consistent immune response patterns in COVID-19 infected patients at single-cell resolution 93%
Similar papers in this journal
- Loss of Y in leukocytes as a risk factor for critical COVID-19 in men 94%
- Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients 93%
- Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines 93%
Similar papers in this journal
- Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk 90%
- Exome-wide association study reveals 7 functional variants associated with ex-vivo drug response in acute myeloid leukaemia patients 90%
- Absolute measurement of the tissue origins of cell-free DNA in the healthy state and following paracetamol overdose 89%
Similar papers in this journal
- Single-cell RNA sequencing of Tocilizumab-treated peripheral blood mononuclear cells as an in vitro model of inflammation 94%
- Time-series plasma cell-free DNA analysis reveals disease severity of COVID-19 patients 93%
- SARS-CoV-2 susceptibility and ACE2 gene variations within diverse ethnic backgrounds 91%
Similar papers in this journal
- Genetic analyses of inflammatory polyneuropathy and chronic inflammatory demyelinating polyradiculoneuropathy identified candidate genes 93%
- From GWAS Variant to Function: a Study of ~148,000 Variants for Blood Cell Traits. 92%
- Using Genetics, Genomics, and Transcriptomics to Identify Therapeutic Targets in Juvenile Idiopathic Arthritis 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.